
Biosfer was awarded with the INNOWWIDE: a high competitive European call
Recently our CEO, Núria Amigó, was invited to participate in the first INNOWWIDE Focus Group, a virtual meeting organized by
Discover the most recent news about our Company.

Recently our CEO, Núria Amigó, was invited to participate in the first INNOWWIDE Focus Group, a virtual meeting organized by

El grup de recerca en Immunologia de la Universitat d’Oviedo del qual forma part el Dr. Javier Rodríguez-Carrio ha publicat

The research group in Immunology at the University of Oviedo with the participation of Dr. Javier Rodríguez-Carrio has published a

Our lipoprotein profile, Liposcale (CE), in Cardiovascular Diabetology: “Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on

Our lipoprotein profile, Liposcale (CE), in Cardiovascular Diabetology: “Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on

Estem molt contents d’anunciar que la Societat Espanyola d’Arteriosclerosi ha redactat un consens sobre l’ús clínic de ressonància magnètica nuclear

We are very happy to announce that the Spanish Arteriosclerosis Society has drawn up a consensus on the clinical use

Esta semana se ha celebrado la edición 88 del Congreso de la Sociedad Europea de Arteriosclerosis en formato virtual. Un

This week the 88th edition of the Congress of the European Arteriosclerosis Society was held in virtual format. The congress

“Biosfer Teslab has been a beneficiary of the European Regional Development Fund whose objective is to improve the use and
Abstract Plasma glycoproteins are a composite biomarker of inflammation and can be detected by 1H-NMR. The aim of this study

COVID-19 Hackathon #Endocrine Disruption, #Text mining in #Toxicology, #Bioinformatics #Metabolomics for #biomarker #discovey, #Organ-on-Chip testing… and more We have participated